Cancer Clinical Trials in New Brunswick, New Jersey

4 studies are recruiting for cancer in New Brunswick, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Abatacept in Immune Checkpoint Inhibitor Myocarditis

    The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI). The primary outcome, MACE, is a composite of first occurren…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Robert Wood Johnson University Hospital, New Brunswick, New Jersey
    Locations
    31 in total
    Run by
    Massachusetts General Hospital

    See if you can join NCT05335928 on ClinicalTrials.gov

  2. A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening

    This study engages youth as health advocates to increase cancer screening in their community. The study will evaluate the effectiveness of a youth-led intervention on cancer screening awareness in adults who are overdue for cancer screening.

    Stage
    Not phased
    Ages
    15 to 80
    Site
    New Brunswick Health Sciences Technology High School, New Brunswick, New Jersey
    Run by
    Rutgers, The State University of New Jersey

    See if you can join NCT07008781 on ClinicalTrials.gov

  3. Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

    This is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at one 1 or more dosi…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
    Locations
    17 in total
    Run by
    MBrace Therapeutics

    See if you can join NCT06014658 on ClinicalTrials.gov

  4. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

    Stage
    Not phased
    Ages
    Any age
    Site
    Massive Bio SYNERGY-AI site, New Brunswick, New Jersey
    Locations
    68 in total
    Run by
    Massive Bio, Inc.

    See if you can join NCT03452774 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.